Celitron has introduced its tailor-made biological infectious waste treatment system for vaccine production at the recent Disposable Solutions for Biomanufacturing Exhibition & Conference.

The conference took place between 29 February and 2 March in Munich, Germany.

Treatment of infectious disposables in biomanufacturing

The disposable biomanufacturing industry is growing rapidly, providing efficiency in GMP and generating further challenges in the disposal of biological infectious single-use equipment under the scope of eliminating any risks of cross-contamination.

Celitron offers custom-made solution for biological infectious waste disposal in vaccine production with completely automated process cycles.

Personalised and fully automatic process for treating used disposables

The system is designed for on-site conversion of biological infectious disposables like vaccines, human insulin, serums, plasma fractions and cell cultures and uses only steam as the sterilizing agent.

By shredding the waste within a pressurised vessel, the volume of the waste is reduced to as little as 1/10th of its original volume, giving further opportunity for recycling.

The system includes:

1. Airtight connection to the clean room(s) – airlock
2. Automatic waste transportation through sliding system – pipeline transport
3. Compactor – for volume reduction
4. Treatment with the ISS – sterilising and shredding within a single pressure vessel
5. Automatic unloading into municipal waste container – conveyor belt

There is also system cleaning, sterilising the whole system by steam (SIP – sterilisation in place).

Customised system with compulsory parameters for Biomanufacturing

Due to direct connections to clean rooms (where the waste is generated) through airlock system, there is no need for a designated storage area for the biological infectious disposables, as it can be disposed of immediately, without the risk of cross-contamination.

All elements, sterilisation cycles and parameters are customised according to the site requirements and the compulsory parameters provided by the vaccine manufacturer in order to secure reliable, simple and safe operation.

Eliminate risk of cross-contamination – secure GMP

In institutions and manufacturing sites, where large amount of live viruses and bacteria are in use, this is essential, as failure to comply generates risk for health and safety.

With this system for handling hazardous waste on-site, vaccine producers can secure their GMP and have the advantage of an effective, immediate and prompt solution for the disposal of the biological infectious waste.

Celitron’s fully automatic, closed system complies with life science laboratory standards (B Class), minimises the risk of cross-contamination, shortens waste handling process and reduces associated costs.